ANDA 84771, held by Barr. Hydrochlorothiazide.
As of Nov 16, 2026, ANDA 84771 (Hydrochlorothiazide), held by Barr, was first approved by FDA on Apr 1, 1977, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 1, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrochlorothiazide50MG ยท tablet;oral | Hydrochlorothiazide | Discontinued |
| Aug 18, 1992 | Supplement 18Labeling | Approved | None posted |
| May 29, 1991 | Supplement 14Labeling | Approved | None posted |
| Apr 1, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters